Colleen Moretti, Assistant Editor for CURE®, joined MJH Life Sciences in November 2020. Colleen is a graduate of Monmouth University, where she studied communication with a focus in journalism and public relations. In her free time, she enjoys learning to cook new meals, spending time with her adopted beagle, Molly, or sitting on the beach with a good book. Email her at cmoretti@curetoday.com
Yoga May Improve Quality of Life, Survival in Patients With Non-Metastatic Breast Cancer
December 13th 2022Improvements may not be seen right away, but patients with non-metastatic breast cancer should stay compliant to practicing yoga to possibly improve quality of life, according to an expert.
Read More
Educated Patient® Multiple Myeloma Summit Immunotherapy Presentation: November 13, 2022
December 3rd 2022Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.
Read More
FDA Fast Tracks Pelareorep Combination for Patients with Subtype of a Pancreatic Cancer
December 2nd 2022The combination of pelareorep, Tecentriq, gemcitabine and Abraxane was granted FDA fast-track designation after demonstrating a 69% objective response rate in patients with advanced/metastatic pancreatic ductal adenocarcinoma.
Read More
HIIT Workouts May Better Reduce Stress and Anxiety in Certain Patients With Prostate Cancer
October 18th 2022A patient with prostate cancer under active surveillance may encounter the fear that their cancer might progress, causing stress and anxiety. However, HIIT workouts may help put them at ease.
Read More
Inflammation May Predict Chemotherapy-Induced Weakness in Older Women With Breast Cancer
October 6th 2022High levels of inflammation, as well as high BMI and later-stage disease, may be predictors of weakness after chemotherapy treatment in older patients with breast cancer, which may hold potential in guiding treatment decisions.
Read More